Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07382258 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 2, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Novlead Inc.
5 trials monitored
See all monitored trials
COPD
1,119 trials monitored
See 34 trials at risk
This clinical trial aims to assess the impact on exercise tolerance and the safety of inhaled nitric oxide in subjects with moderate-to-severe COPD. The findings are expected to contribute to the development of safe and effective therapeutic strategies for COPD management.
Trial Details
NCT Number NCT07382258
Lead Sponsor Novlead Inc.
Collaborators: The First Affiliated Hospital with Nanjing Medical University
Conditions
(from sponsor)		 Chronic Obstructive Pulmonary Disease (COPD)
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov